Cytotoxic FCER1G
+
innate-like T cells: new potential for tumour immunotherapy
Signal Transduct Target Ther
.
2022 Jun 29;7(1):204.
doi: 10.1038/s41392-022-01061-4.
Authors
Emma Morrish
1
2
3
,
Jürgen Ruland
4
5
6
7
Affiliations
1
Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
2
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.
3
German Cancer Consortium (DKTK), Heidelberg, Germany.
4
Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany. j.ruland@tum.de.
5
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany. j.ruland@tum.de.
6
German Cancer Consortium (DKTK), Heidelberg, Germany. j.ruland@tum.de.
7
German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany. j.ruland@tum.de.
PMID:
35768418
PMCID:
PMC9243043
DOI:
10.1038/s41392-022-01061-4
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antineoplastic Agents*
Humans
Immunotherapy
Neoplasms* / genetics
Neoplasms* / therapy
T-Lymphocytes, Cytotoxic
Substances
Antineoplastic Agents